Sarah S Knox1. 1. Program in Clinical and Population Epigenetics, Dept, of Community Medicine West Virginia University School of Medicine, PO Box 9190, Health Science South Morgantown, WV 26506, USA. sknox@hsc.wvu.edu.
Abstract
BACKGROUND: Cancer is a complex disease that involves a sequence of gene-environment interactions in a progressive process that cannot occur without dysfunction in multiple systems, including DNA repair, apoptotic and immune functions. Epigenetic mechanisms, responding to numerous internal and external cues in a dynamic ongoing exchange, play a key role in mediating environmental influences on gene expression and tumor development. HYPOTHESIS: The hypothesis put forth in this paper addresses the limited success of treatment outcomes in clinical oncology. It states that improvement in treatment efficacy requires a new paradigm that focuses on reversing systemic dysfunction and tailoring treatments to specific stages in the process. It requires moving from a reductionist framework of seeking to destroy aberrant cells and pathways to a transdisciplinary systems biology approach aimed at reversing multiple levels of dysfunction. CONCLUSION: Because there are many biological pathways and multiple epigenetic influences working simultaneously in the expression of cancer phenotypes, studying individual components in isolation does not allow an adequate understanding of phenotypic expression. A systems biology approach using new modeling techniques and nonlinear mathematics is needed to investigate gene-environment interactions and improve treatment efficacy. A broader array of study designs will also be required, including prospective molecular epidemiology, immune competent animal models and in vitro/in vivo translational research that more accurately reflects the complex process of tumor initiation and progression.
BACKGROUND:Cancer is a complex disease that involves a sequence of gene-environment interactions in a progressive process that cannot occur without dysfunction in multiple systems, including DNA repair, apoptotic and immune functions. Epigenetic mechanisms, responding to numerous internal and external cues in a dynamic ongoing exchange, play a key role in mediating environmental influences on gene expression and tumor development. HYPOTHESIS: The hypothesis put forth in this paper addresses the limited success of treatment outcomes in clinical oncology. It states that improvement in treatment efficacy requires a new paradigm that focuses on reversing systemic dysfunction and tailoring treatments to specific stages in the process. It requires moving from a reductionist framework of seeking to destroy aberrant cells and pathways to a transdisciplinary systems biology approach aimed at reversing multiple levels of dysfunction. CONCLUSION: Because there are many biological pathways and multiple epigenetic influences working simultaneously in the expression of cancer phenotypes, studying individual components in isolation does not allow an adequate understanding of phenotypic expression. A systems biology approach using new modeling techniques and nonlinear mathematics is needed to investigate gene-environment interactions and improve treatment efficacy. A broader array of study designs will also be required, including prospective molecular epidemiology, immune competent animal models and in vitro/in vivo translational research that more accurately reflects the complex process of tumor initiation and progression.
Authors: Marten Scheffer; Jordi Bascompte; William A Brock; Victor Brovkin; Stephen R Carpenter; Vasilis Dakos; Hermann Held; Egbert H van Nes; Max Rietkerk; George Sugihara Journal: Nature Date: 2009-09-03 Impact factor: 49.962
Authors: Kevin K Divine; Leah C Pulling; Patricia G Marron-Terada; Kieu C Liechty; Terri Kang; Ann G Schwartz; Therese J Bocklage; Teresa A Coons; Frank D Gilliland; Steven A Belinsky Journal: Int J Cancer Date: 2005-04-10 Impact factor: 7.396
Authors: Ming Zhu Fang; Yimin Wang; Ni Ai; Zhe Hou; Yi Sun; Hong Lu; William Welsh; Chung S Yang Journal: Cancer Res Date: 2003-11-15 Impact factor: 12.701
Authors: Christine A Stidley; Maria A Picchi; Shuguang Leng; Randy Willink; Richard E Crowell; Kristina G Flores; Huining Kang; Tim Byers; Frank D Gilliland; Steven A Belinsky Journal: Cancer Res Date: 2010-01-12 Impact factor: 12.701
Authors: Dominik Pretscher; Luitpold V Distel; Gerhard G Grabenbauer; Michael Wittlinger; Maike Buettner; Gerald Niedobitek Journal: BMC Cancer Date: 2009-08-22 Impact factor: 4.430